Roche Holding AG

ISIN CH0012032113 Symbol RO Industry Drug Manufacturers-General Sector Healthcare
Roche Price
390.6CHF 0.41%
1y Low: 284.1
1y High: 344.7
1y Low: 284.1
1y High: 344.7
roche.com
Market Cap
291.9 B USD
Dividend Yield
2.8%
Performance 1y
16.46 %
PER
20.4

Roche Stock Chart

Roche Dividend Chart

Roche Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 1 9.10 CHF 2.4 %
2020 1 9.00 CHF 2.9 %
2019 1 8.70 CHF 2.8 %
2018 1 8.30 CHF 3.4 %
2017 1 8.20 CHF 3.3 %
2016 1 8.10 CHF 3.4 %
2015 1 8.00 CHF 2.9 %
2014 1 7.80 CHF 2.9 %
2013 1 7.35 CHF 3.0 %
2012 1 6.80 CHF 3.6 %
2011 1 6.60 CHF 4.0 %
2010 1 6.00 CHF 4.2 %
2009 1 5.00 CHF 2.8 %
2008 1 4.60 CHF 2.7 %
2007 1 3.40 CHF 1.6 %
2006 2 2.75 CHF 1.1 %
2005 2 2.41 CHF 1.1 %
2004 1 1.65 CHF 1.1 %
2003 1 1.45 CHF 0.8 %
2002 1 1.30 CHF 0.7 %
2001 1 1.15 CHF 0.9 %
2000 1 1.00 CHF 0.5 %
1999 1 0.87 CHF 0.3 %
1998 1 0.83 CHF 0.3 %
1997 1 0.75 CHF 0.4 %
1996 1 0.36 CHF 0.2 %

Roche Performance

1 Week
1 Month
6 Months
20.48 %
Year to Date
25.27 %
1 Year
16.46 %
5 Years
59.75 %

Roche Revenue, EBIT, and Income

Roche Margins

Roche Shares Outstanding

Useful Links

Search Twitter: $RO, #RO

Roche Company Info

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Further, the company discovers, develops, and delivers gene therapies. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19; collaboration and license agreement with Lead Pharma Holding B.V. to develop oral small molecules to treat a range of immune mediated diseases; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Roche Price to Earnings Ratio (PE Ratio): 20.4

The current Price to Earnings Ratio of Roche is 20.4.
The PE Ratio is calcluated by dividing the current Roche share price (390.6 CHF) by the earnings per share (16.5).

Roche Dividend Yield: 2.8%

The current Dividend Yield of Roche is 2.8%.

Roche Market Cap: 291.9 B USD

The current market cap of Roche is 291.9 B USD.

Roche Stock Price: 390.6 CHF

The current stock price of Roche is 390.6 CHF (413.7 USD).

Roche ISIN: CH0012032113

The ISIN (International Securities Identification Number) of Roche is CH0012032113.

Roche Ticker Symbol: RO

The ticker symbol of Roche is RO.

Roche Address

The address of the Roche HQ is Konzern Hauptsitz, 4070 Basel, Switzerland.